Extracellular Vesicular miRNA in Pancreatic Cancer: From Lab to Therapy.
Prashant Kumar TiwariPoojhaa ShanmugamVamika KarnSaurabh GuptaRicha MishraSarvesh RustagiMandeep ChouhanDevvret VermaNiraj Kumar JhaSanjay KumarPublished in: Cancers (2024)
Pancreatic cancer is a prevalent lethal gastrointestinal cancer that generally does not show any symptoms until it reaches advanced stages, resulting in a high mortality rate. People at high risk, such as those with a family history or chronic pancreatitis, do not have a universally accepted screening protocol. Chemotherapy and radiotherapy demonstrate limited effectiveness in the management of pancreatic cancer, emphasizing the urgent need for innovative therapeutic strategies. Recent studies indicated that the complex interaction among pancreatic cancer cells within the dynamic microenvironment, comprising the extracellular matrix, cancer-associated cells, and diverse immune cells, intricately regulates the biological characteristics of the disease. Additionally, mounting evidence suggests that EVs play a crucial role as mediators in intercellular communication by the transportation of different biomolecules, such as miRNA, proteins, DNA, mRNA, and lipids, between heterogeneous cell subpopulations. This communication mediated by EVs significantly impacts multiple aspects of pancreatic cancer pathogenesis, including proliferation, angiogenesis, metastasis, and resistance to therapy. In this review, we delve into the pivotal role of EV-associated miRNAs in the progression, metastasis, and development of drug resistance in pancreatic cancer as well as their therapeutic potential as biomarkers and drug-delivery mechanisms for the management of pancreatic cancer.
Keyphrases
- extracellular matrix
- drug delivery
- randomized controlled trial
- systematic review
- early stage
- stem cells
- radiation therapy
- locally advanced
- squamous cell carcinoma
- cell therapy
- mesenchymal stem cells
- single molecule
- signaling pathway
- vascular endothelial growth factor
- depressive symptoms
- cardiovascular events
- cardiovascular disease
- young adults
- cancer therapy
- rectal cancer
- circulating tumor cells
- cell adhesion